Zobrazeno 1 - 10
of 58
pro vyhledávání: '"PIOTR KRAMARZ"'
Autor:
Constantine I. Vardavas, Alexander G. Mathioudakis, Katerina Nikitara, Kimon Stamatelopoulos, Georgios Georgiopoulos, Revati Phalkey, Jo Leonardi-Bee, Esteve Fernandez, Dolors Carnicer-Pont, Jørgen Vestbo, Jan C. Semenza, Charlotte Deogan, Jonathan E. Suk, Piotr Kramarz, Favelle Lamb, Pasi Penttinen
Publikováno v:
European Respiratory Review, Vol 31, Iss 166 (2022)
Background As mortality from coronavirus disease 2019 (COVID-19) is strongly age-dependent, we aimed to identify population subgroups at an elevated risk for adverse outcomes from COVID-19 using age-/gender-adjusted data from European cohort studies
Externí odkaz:
https://doaj.org/article/bedc2fbae6f84b1ab55ce1888b20446b
Autor:
Edoardo Colzani, Alessandro Cassini, Daniel Lewandowski, Marie-Josee J Mangen, Dietrich Plass, Scott A McDonald, Alies van Lier, Juanita A Haagsma, Guido Maringhini, Alessandro Pini, Piotr Kramarz, Mirjam E Kretzschmar
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0170662 (2017)
The burden of disease framework facilitates the assessment of the health impact of diseases through the use of summary measures of population health such as Disability-Adjusted Life Years (DALYs). However, calculating, interpreting and communicating
Externí odkaz:
https://doaj.org/article/49c8783c78234c87b07655bbe50fdc7c
Autor:
Alessandro Cassini, Diamantis Plachouras, Tim Eckmanns, Muna Abu Sin, Hans-Peter Blank, Tanja Ducomble, Sebastian Haller, Thomas Harder, Anja Klingeberg, Madlen Sixtensson, Edward Velasco, Bettina Weiß, Piotr Kramarz, Dominique L Monnet, Mirjam E Kretzschmar, Carl Suetens
Publikováno v:
PLoS Medicine, Vol 13, Iss 10, p e1002150 (2016)
Estimating the burden of healthcare-associated infections (HAIs) compared to other communicable diseases is an ongoing challenge given the need for good quality data on the incidence of these infections and the involved comorbidities. Based on the me
Externí odkaz:
https://doaj.org/article/6fa1b782ca8747358b242c225ab05dac
Autor:
Silvana Romio, Daniel Weibel, Jeanne P Dieleman, Henning K Olberg, Corinne S de Vries, Cormac Sammon, Nick Andrews, Henrik Svanström, Ditte Mølgaard-Nielsen, Anders Hviid, Maryse Lapeyre-Mestre, Agnès Sommet, Christel Saussier, Anne Castot, Harald Heijbel, Lisen Arnheim-Dahlström, Par Sparen, Mees Mosseveld, Martijn Schuemie, Nicoline van der Maas, Bart C Jacobs, Tuija Leino, Terhi Kilpi, Jann Storsaeter, Kari Johansen, Piotr Kramarz, Jan Bonhoeffer, Miriam C J M Sturkenboom
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e82222 (2014)
BACKGROUND: The risk of Guillain-Barré syndrome (GBS) following the United States' 1976 swine flu vaccination campaign in the USA led to enhanced active surveillance during the pandemic influenza (A(H1N1)pdm09) immunization campaign. This study aime
Externí odkaz:
https://doaj.org/article/f01b0db04e964ceaaa28e383d0df1744
Autor:
Marie-Josée J Mangen, Dietrich Plass, Arie H Havelaar, Cheryl L Gibbons, Alessandro Cassini, Nikolai Mühlberger, Alies van Lier, Juanita A Haagsma, R John Brooke, Taavi Lai, Chiara de Waure, Piotr Kramarz, Mirjam E E Kretzschmar, BCoDE consortium
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e79740 (2013)
In 2009, the European Centre for Disease Prevention and Control initiated the 'Burden of Communicable Diseases in Europe (BCoDE)' project to generate evidence-based and comparable burden-of-disease estimates of infectious diseases in Europe. The burd
Externí odkaz:
https://doaj.org/article/0b5f46cb378548609c456ce5015a35cd
Autor:
Marie-Josée J. Mangen, Dietrich Plass, Arie H. Havelaar, Cheryl L. Gibbons, Alessandro Cassini, Nikolai Mühlberger, Alies van Lier, Juanita A. Haagsma, R. John Brooke, Taavi Lai, Chiara de Waure, Piotr Kramarz, Mirjam E. E. Kretzschmar
Publikováno v:
PLoS ONE, Vol 8, Iss 12 (2013)
Externí odkaz:
https://doaj.org/article/5880a08f08d142a09f7893193739aa9a
Autor:
Mirjam Kretzschmar, Marie-Josée J Mangen, Paulo Pinheiro, Beate Jahn, Eric M Fèvre, Silvia Longhi, Taavi Lai, Arie H Havelaar, Claudia Stein, Alessandro Cassini, Piotr Kramarz, BCoDE consortium
Publikováno v:
PLoS Medicine, Vol 9, Iss 4, p e1001205 (2012)
Mirjam Kretzschmar and colleagues describe the BCoDE project, which uses a pathogen-based incidence approach to better estimate the infectious disease burden in Europe.
Externí odkaz:
https://doaj.org/article/38ffb43213a64fd0b187c7c3180da141
Autor:
Marta Valenciano, Esther Kissling, Jean-Marie Cohen, Beatrix Oroszi, Anne-Sophie Barret, Caterina Rizzo, Baltazar Nunes, Daniela Pitigoi, Amparro Larrauri Cámara, Anne Mosnier, Judith K Horvath, Joan O'Donnell, Antonino Bella, Raquel Guiomar, Emilia Lupulescu, Camelia Savulescu, Bruno C Ciancio, Piotr Kramarz, Alain Moren
Publikováno v:
PLoS Medicine, Vol 8, Iss 1, p e1000388 (2011)
BackgroundA multicentre case-control study based on sentinel practitioner surveillance networks from seven European countries was undertaken to estimate the effectiveness of 2009-2010 pandemic and seasonal influenza vaccines against medically attende
Externí odkaz:
https://doaj.org/article/0f23629a956346d0b90c7cb1b96c8530
Autor:
Julien Beauté, Piotr Kramarz
Publikováno v:
Eurosurveillance. 27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07891d386da45162ce5adf97576f2227
https://doi.org/10.2807/1560-7917.es.2022.27.22.2200430
https://doi.org/10.2807/1560-7917.es.2022.27.22.2200430
Autor:
Maarit H Kokki, Lina Titievsky, Miriam C. J. M. Sturkenboom, Simon de Lusignan, Patrick Mahy, Susan Hahné, Vincent Bauchau, Heidi J. Larson, Alena Khromava, Laurence Torcel-Pagnon, Tyra Grove Krause, Antonella Chiucchiuini, Piotr Kramarz, Xavier Kurz, Priya Bahri
Publikováno v:
Vaccine. 38:B1-B7
The influenza A/H1N1 pandemic in 2009 taught us that the monitoring of vaccine benefits and risks in Europe had potential for improvement if different public and private stakeholders would collaborate better (public health institutes (PHIs), regulato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58db55085ee198063f2fffa73431fe2e
https://doi.org/10.1016/j.vaccine.2019.07.081
https://doi.org/10.1016/j.vaccine.2019.07.081